About T-knife Therapeutics

Website
Website
Employees
Employees
51-200 employees View all
Industry
Industry
Biotechnology
Location
Location
San Francisco,US
Description
Information
We are a fast-growing, pre-clinical-stage biopharmaceutical company developing tumor-specific T cell receptor (TCR) therapies. Our dynamic, international team sets out with the ambitious goal to revolutionize the TCR landscape using our unique and proprietary transgenic HuTCR mouse platform to produce fully human TCRs for the treatment of cancer. To achieve this ambitious goal, we have successfully completed Series A financing with top-tier investors in August 2020.

T-knife Therapeutics Alternatives

Industry
Biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
biotechnology

Frequently Asked Questions about T-knife Therapeutics

What is T-knife Therapeutics email format?

The widely used T-knife Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is T-knife Therapeutics customer service number?

To contact T-knife Therapeutics customer service number in your country click here to find.


Who is the CEO of T-knife Therapeutics?

Danielle Delorio is the CEO of T-knife Therapeutics. To contact Danielle Delorio email at [email protected].


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more